Cargando…
Treatment-Free Remission: the New Goal in CML Therapy
PURPOSE OF REVIEW: Treatment-free remission (TFR) is considered one of the main goals of therapy in patients with CML. Our goal in this paper is to review the current data on TFR, and discuss future directions. RECENT FINDINGS: Multiple studies have demonstrated that attempting a treatment-free remi...
Autores principales: | Atallah, Ehab, Sweet, Kendra |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495665/ https://www.ncbi.nlm.nih.gov/pubmed/34618317 http://dx.doi.org/10.1007/s11899-021-00653-1 |
Ejemplares similares
-
Is There a Role for Dose Modification of TKI Therapy in CML?
por: Copland, M.
Publicado: (2019) -
Tyrosine Kinase Inhibitor Therapy Discontinuation for Patients with Chronic Myeloid Leukaemia in Clinical Practice
por: Clark, Richard E.
Publicado: (2019) -
Towards a Personalized Treatment of Patients with Chronic Myeloid Leukemia
por: Rabian, Florence, et al.
Publicado: (2019) -
Treatment-free remission in chronic myeloid leukemia patients treated front-line with nilotinib: 10-year follow-up of the GIMEMA CML 0307 study
por: Gugliotta, Gabriele, et al.
Publicado: (2022) -
NGS in CML - New standard diagnostic procedure?
por: Branford, Susan, et al.
Publicado: (2019)